PODXL2
Podocalyxin-like protein 2
Also known as: endoglycan, PDXL2_HUMAN, PODLX2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZ53
- Gene
- PODXL2
- Ensembl
- ENSG00000114631
- Chromosome
- 3
- Canonical length
- 605 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Golgi apparatus,Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene is a member of the CD34 family of cell surface transmembrane proteins, which are characterized by an N-terminal extracellular mucin domain, globular and stalk domains, a single pass transmembrane region, and a charged cytoplasmic tail. The encoded protein is a ligand for vascular selectins. [provided by RefSeq, Oct 2012]
Canonical amino-acid sequenceUniProt
605 residues, UniProt reviewed canonical sequence.
>Q9NZ53|PODXL2
1 MGRLLRAARL PPLLSPLLLL LVGGAFLGAC VAGSDEPGPE GLTSTSLLDL LLPTGLEPLD
61 SEEPSETMGL GAGLGAPGSG FPSEENEESR ILQPPQYFWE EEEELNDSSL DLGPTADYVF
121 PDLTEKAGSI EDTSQAQELP NLPSPLPKMN LVEPPWHMPP REEEEEEEEE EEREKEEVEK
181 QEEEEEEELL PVNGSQEEAK PQVRDFSLTS SSQTPGATKS RHEDSGDQAS SGVEVESSMG
241 PSLLLPSVTP TTVTPGDQDS TSQEAEATVL PAAGLGVEFE APQEASEEAT AGAAGLSGQH
301 EEVPALPSFP QTTAPSGAEH PDEDPLGSRT SASSPLAPGD MELTPSSATL GQEDLNQQLL
361 EGQAAEAQSR IPWDSTQVIC KDWSNLAGKN YIILNMTENI DCEVFRQHRG PQLLALVEEV
421 LPRHGSGHHG AWHISLSKPS EKEQHLLMTL VGEQGVVPTQ DVLSMLGDIR RSLEEIGIQN
481 YSTTSSCQAR ASQVRSDYGT LFVVLVVIGA ICIIIIALGL LYNCWQRRLP KLKHVSHGEE
541 LRFVENGCHD NPTLDVASDS QSEMQEKHPS LNGGGALNGP GSWGALMGGK RDPEDSDVFE
601 EDTHLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PODXL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 99 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 99 nTPM
- cerebellum: 82 nTPM
- cerebral cortex: 68 nTPM
- hippocampal formation: 61 nTPM
- pituitary gland: 56 nTPM
- midbrain: 54 nTPM
Single-cell type
- late spermatids: 267 nCPM
- undifferentiated spermatogonia: 122 nCPM
- other brain neurons: 98 nCPM
- brain inhibitory neurons: 73 nCPM
- differentiating spermatogonia: 70 nCPM
- late primary spermatocytes: 68 nCPM
Immune cell
- memory CD4 T-cell: 0.6 nTPM
- plasmacytoid DC: 0.6 nTPM
- T-reg: 0.5 nTPM
- MAIT T-cell: 0.3 nTPM
- memory B-cell: 0.3 nTPM
- naive CD4 T-cell: 0.3 nTPM
Brain region
- hypothalamus: 142 nTPM
- pons: 121 nTPM
- midbrain: 112 nTPM
- cerebral cortex: 101 nTPM
- medulla oblongata: 101 nTPM
- basal ganglia: 97 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.14
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.91
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- CD34/Podocalyxin
- CD34/Podocalyxin family
- Podocalyxin-like protein 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PODXL2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PODXL2 as an antibody target. Whether an autoantibody or antibody against PODXL2 could matter depends on whether native PODXL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PODXL2 is annotated at the cell surface, where native PODXL2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PODXL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...